Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap small cap stocks to buy now. Nortiva Bio, Inc., which is a wholly owned subsidiary of Innoviva, Inc. (NASDAQ:INVA), announced on June 18 its launch as a clinical-stage biopharmaceutical company dedicated to the development of long-acting oral medicines using its proprietary LYNX™ drug delivery platform. Innoviva, Inc. acquired the LYNX platform from Lyndra Therapeutics, Inc. in 2025, with the platform capable of transforming daily pills into long-acting oral therapies with single doses that last up to a month in multiple therapeutic areas. Management stated that the advancement can improve medication adherence, optimize efficacy and safety, and positively impact patients’ quality of life.
It further stated that the LYNX platform is built on “foundational science from the labs of Robert Langer and Gio Traverso at MIT”, bolstered by years of clinical validation, development, and research, which includes proof of concept in multiple therapeutic areas and a successful Phase 3 study.
Innoviva, Inc. is involved in the development, commercialization, and financial management of biopharmaceuticals.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
